| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4026078 | Ophthalmology | 2014 | 8 Pages |
Abstract
Acanthamoeba sclerokeratitis is associated with poor clinical outcomes. Management of ASK with anti-inflammatory/immunosuppressive treatment is usually effective in reducing both scleral inflammation and symptoms and possibly reduces the number of enucleations.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Alfonso MD, PhD, Daniel M. MD, FRCOphth, Nicole B.Optom, PhD, John K. MD, FRCOphth,